Satoshi Itasaka

3.6k total citations · 1 hit paper
70 papers, 2.7k citations indexed

About

Satoshi Itasaka is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Satoshi Itasaka has authored 70 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 27 papers in Cancer Research and 20 papers in Oncology. Recurrent topics in Satoshi Itasaka's work include Cancer, Hypoxia, and Metabolism (25 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Esophageal Cancer Research and Treatment (9 papers). Satoshi Itasaka is often cited by papers focused on Cancer, Hypoxia, and Metabolism (25 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Esophageal Cancer Research and Treatment (9 papers). Satoshi Itasaka collaborates with scholars based in Japan, China and United States. Satoshi Itasaka's co-authors include Masahiro Hiraoka, Hiroshi Harada, Akiyo Morinibu, Kazumi Shinomiya, Michio Yoshimura, Keiko Shibuya, Kiichi Hirota, Guangfei Ou, Shinae Kizaka‐Kondoh and Lihua Zeng and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Satoshi Itasaka

68 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Correction: Corrigendum: Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate toward tumour blood vessels

2013 621 citations Hiroshi Harada, Satoshi Itasaka et al. profile →

Peers

Countries citing papers authored by Satoshi Itasaka

Since Specialization

Citations

This map shows the geographic impact of Satoshi Itasaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Itasaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Itasaka more than expected).

Fields of papers citing papers by Satoshi Itasaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Itasaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Itasaka. The network helps show where Satoshi Itasaka may publish in the future.

Co-authorship network of co-authors of Satoshi Itasaka

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Itasaka. A scholar is included among the top collaborators of Satoshi Itasaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Itasaka. Satoshi Itasaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Arm-Behind-the-Back Position for Breast Cancer Radiotherapy in Patients with Lupus Erythematosus and Shoulder Arthropathy: A Case Report 2025 ·American Journal of Case Reports ·(unknown), Kota Fujii, (unknown), (unknown), (unknown), (unknown), Kenji Notohara, (unknown), Satoshi Itasaka	0
2	Dosimetric comparison of pencil beam scanning proton therapy with or without multi-leaf collimator versus volumetric-modulated arc therapy for treatment of malignant glioma 2023 ·Medical dosimetry ·(unknown), Yuki Tominaga, (unknown), (unknown), (unknown), (unknown), Satoshi Itasaka, Masataka Oita, Masahiro Kuroda	3
3	Stereotactic body radiation therapy versus radiofrequency ablation for single small hepatocellular carcinoma: a propensity-score matching analysis of their impact on liver function and clinical outcomes 2021 ·Journal of Gastrointestinal Oncology ·Masayuki Ueno, Hiroyuki Takabatake, Satoshi Itasaka, Takahisa Kayahara, Youichi Morimoto, Hiroshi Yamamoto, Motowo Mizuno	7
4	Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma 2020 ·Radiation Oncology ·(unknown), Michio Yoshimura, Ryo Ashida, Yökö Gotö, Takahiro Kishi, Satoshi Itasaka, Keiko Shibuya, Masashi Kanai, Toshihiko Masui, Akihisa Fukuda, Hiroyoshi Isoda, Masahiro Hiraoka, Takashi Mizowaki	6
5	Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer 2018 ·Radiation Oncology ·Yökö Gotö, Akira Nakamura, Ryo Ashida, Katsuyuki Sakanaka, Satoshi Itasaka, Keiko Shibuya, Shigemi Matsumoto, Masashi Kanai, Hiroyoshi Isoda, Toshihiko Masui, Yuzo Kodama, Kyoichi Takaori, Masahiro Hiraoka, Takashi Mizowaki	31
6	Evaluation of Dynamic Tumor-tracking Intensity-modulated Radiotherapy for Locally Advanced Pancreatic Cancer 2018 ·Scientific Reports ·Akira Nakamura, Masahiro Hiraoka, Satoshi Itasaka, Mitsuhiro Nakamura, (unknown), (unknown), Nobutaka Mukumoto, Yökö Gotö, Takahiro Kishi, Michio Yoshimura, Yukinori Matsuo, Shinsuke Yano, Takashi Mizowaki	14
7	A Prospective Study of Intensity-modified Radiation Therapy in Comparison with Conventional 3D-RT for BR Pancreatic Cancer Patients with Arterial Involvement 2017 ·Anticancer Research ·Toshihiko Masui, Kyoichi Takaori, Takayuki Anazawa, Asahi Sato, (unknown), Yuichiro Uchida, (unknown), Yökö Gotö, Shigemi Matsumoto, Yuzo Kodama, Masashi Kanai, Hiroyoshi Isoda, Masashi Mizumoto, Yoshiya Kawaguchi, Keiko Shibuya, Satoshi Itasaka, Shinji Üemoto	4
8	PLK1 blockade enhances therapeutic effects of radiation by inducing cell cycle arrest at the mitotic phase 2015 ·Scientific Reports ·Minoru Inoue, Michio Yoshimura, Minoru Kobayashi, Akiyo Morinibu, Satoshi Itasaka, Masahiro Hiraoka, Hiroshi Harada	16
9	Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer 2015 ·Pancreatology ·Takahiro Kishi, Akira Nakamura, Satoshi Itasaka, Keiko Shibuya, Shigemi Matsumoto, Masashi Kanai, Yuzo Kodama, Kyoichi Takaori, Takashi Mizowaki, Masahiro Hiraoka	25
10	Evaluation of Novel Orthotopic Nude Mouse Models for Human Small-Cell Lung Cancer 2013 ·Journal of Thoracic Oncology ·Takeshi Isobe, Amir Onn, Daniel Morgensztern, Jörg J. Jacoby, Wenjuan Wu, Tomoaki Shintani, Satoshi Itasaka, Keiko Shibuya, (unknown), Michael S. O’Reilly, Roy S. Herbst	26
11	Involvement of decreased hypoxia-inducible factor 1 activity and resultant G1–S cell cycle transition in radioresistance of perinecrotic tumor cells 2012 ·Oncogene ·Yuxi Zhu, Tao Zhao, Satoshi Itasaka, Zeng Li, Chan Joo Yeom, Kiichi Hirota, Keiji Suzuki, Akiyo Morinibu, Kazumi Shinomiya, George Ou, Michio Yoshimura, Masahiro Hiraoka, Hiroshi Harada	26
12	Delayed Initial Radioactive Iodine Therapy Resulted in Poor Survival in Patients with Metastatic Differentiated Thyroid Carcinoma: A Retrospective Statistical Analysis of 198 Cases 2011 ·Journal of Nuclear Medicine ·Tatsuya Higashi, Ryuichi Nishii, Shigeki Yamada, Yuji Nakamoto, Koichi Ishizu, (unknown), Kaori Togashi, Satoshi Itasaka, Masahiro Hiraoka, Takashi Misaki, Junji Konishi	57
13	Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Satoshi Itasaka, Ritsuko Komaki, Roy S. Herbst, Keiko Shibuya, Tomoaki Shintani, Nancy Hunter, Amir Onn, Corazon D. Bucana, Luka Milas, K. Kian Ang, Michael S. O’Reilly	41
14	Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model 2006 ·Oncology Reports ·Jung-Il Lee, Satoshi Itasaka, Ji Hong Kim, Do‐Hyun Nam	9
15	Combined blockade of VEGFR and EGFR with ZD6474 enhances the antitumor and antivascular effects of radiation therapy in an orthotopic mouse model of human lung cancer 2005 ·Cancer Research ·Kazunori Shibuya, Ritsuko Komaki, Takashi Shintani, Wei-Kang Wu, Satoshi Itasaka, Takeshi Isobe, Anderson J. Ryan, Roy S. Herbst, Martin O’Reilly	1
16	ZD6474, a small molecule targeting VEGF and EGF receptor signaling, inhibits lung angiogenesis and metastasis and improves survival in an orthotopic model of non-small cell lung cancer 2004 ·Cancer Research ·Wenjuan Wu, Takeshi Isobe, Satoshi Itasaka, Tomoaki Shintani, Robert R. Langley, Amir Onn, (unknown), Michael S. O’Reilly, Roy S. Herbst	12
17	Targeted therapy against VEGF and EGF receptor signaling with ZD6474 blocks angiogenesis and inhibits the growth and dissemination of orthotopic human lung cancer in mice. 2003 ·Clinical Cancer Research ·(unknown), Takeshi Isobe, (unknown), Tomoaki Shintani, Satoshi Itasaka, (unknown), Robert R. Langley, (unknown), Isaiah J. Fidler, Anderson J. Ryan	1
18	Appearance of leukoaraiosis may be attenuated with compression by a chronic subdural hematoma 2003 ·European Journal of Radiology ·Satoshi Itasaka, Yukio Miki, Hidekazu Tomimoto, Ichiro Kamei, Kazushige Tsutsui	1
19	Synchrotron Radiation Microangiography System for Observation of Blood Flow in Murine Tumor Vasculature 2001 ·Keiji Umetani, Satoshi Itasaka, Masakazu Ogura, Hiroyuki Kimura, Masahiro Hiraoka	5
20	Intermittent bursts of motor activity in the human rectum and absence of propagation 1993 ·Gastroenterologia Japonica ·(unknown), Satoshi Itasaka, Makoto Ishikawa, Tsuneo Takahashi, Yuichi Suzuki	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact